Valuation: Xiamen Amoytop Biotech Co., Ltd.

Capitalization 33.46B 4.61B 4.39B 4.14B 3.66B 6.54B 400B 7.25B 49.31B 18.27B 167B 17.29B 16.94B 701B P/E ratio 2024 *
42.4x
P/E ratio 2025 * 30.6x
Enterprise value 33.46B 4.61B 4.39B 4.14B 3.66B 6.54B 400B 7.25B 49.31B 18.27B 167B 17.29B 16.94B 701B EV / Sales 2024 *
11.9x
EV / Sales 2025 * 9.03x
Free-Float
31.6%
Yield 2024 *
-
Yield 2025 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.34%
1 week+2.30%
Current month+1.68%
1 month+14.80%
3 months+9.04%
6 months+64.15%
Current year+12.09%
More quotes
1 week
78.85
Extreme 78.85
83.66
1 month
72.05
Extreme 72.05
83.66
Current year
70.22
Extreme 70.22
83.66
1 year
46.30
Extreme 46.3
86.11
3 years
21.32
Extreme 21.32
86.11
5 years
21.32
Extreme 21.32
86.11
10 years
21.32
Extreme 21.32
86.11
More quotes
Director TitleAgeSince
Chief Executive Officer 59 2013-04-30
Director of Finance/CFO 50 2021-09-09
Corporate Officer/Principal 54 1996-08-06
Manager TitleAgeSince
Chairman 59 2014-07-31
Chairman 59 2020-08-30
Director/Board Member 62 2015-08-05
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.34%+2.30%+33.38%+227.52% 4.61B
+1.14%-4.80%-8.31%+5.48% 79.12B
+1.90%+17.90%+40.69%+56.37% 58.36B
-3.58%-4.65%+91.85%+112.44% 35.96B
-0.81%-2.84%-37.79%-35.86% 20.1B
-1.85%-5.48%+327.83%+820.50% 14.59B
+0.59%-5.00%+21.64%+6.66% 13.63B
-0.19%+0.64%+77.55%+141.17% 13.58B
+0.67%+1.44%-24.60%-27.95% 12.36B
+4.31%+0.99%+9.19%-32.53% 11.95B
Average +0.35%-1.43%+53.14%+127.38% 26.43B
Weighted average by Cap. +0.38%-2.25%+39.17%+80.75%
See all sector performances

Financials

2024 *2025 *
Net sales 2.8B 387M 368M 347M 307M 548M 33.49B 608M 4.13B 1.53B 14B 1.45B 1.42B 58.79B 3.71B 511M 487M 459M 405M 724M 44.27B 804M 5.46B 2.02B 18.51B 1.92B 1.88B 77.72B
Net income 819M 113M 107M 101M 89.53M 160M 9.78B 177M 1.21B 447M 4.09B 423M 415M 17.17B 1.1B 151M 144M 136M 120M 214M 13.08B 237M 1.61B 598M 5.47B 566M 555M 22.96B
Net Debt - -
More financial data * Estimated data
Logo Xiamen Amoytop Biotech Co., Ltd.
XIAMEN AMOYTOP BIOTECH CO., LTD is a China-based company mainly engaged in the biopharmaceutical business, including the research, development, manufacture and sales of recombinant proteins and their long-acting modified drugs. The Company's main research and development direction is immune-related cytokine drugs, focusing on systemic immune solutions based on cytokine drugs, and its products mainly include Peginterferon alfa-2b Injection, rhGM-CSF (Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor for Injection), rHuG-CSF (Recombinant Human Granulocyte-Colony Stimulating Factor for Injection) and Recombinant Human Interleukin-11 for Injection. The Company distributes its products within domestic market and to overseas markets.
Employees
1,960
Calendar
More about the company
Date Price Change Volume
25-02-14 82.24 ¥ +1.34% 2,008,535
25-02-13 81.15 ¥ -1.87% 2,481,304
25-02-12 82.70 ¥ +1.36% 2,067,217
25-02-11 81.59 ¥ +2.12% 2,483,581
25-02-10 79.90 ¥ -0.61% 2,511,402

End-of-day quote Shanghai S.E., February 13, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
82.24CNY
Average target price
87.23CNY
Spread / Average Target
+6.07%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688278 Stock